With heightened awareness around water quality and an increased demand for healthier living solutions, Alpine’s new systems are crafted to deliver not only purity but also reliability and peace of ...

We plan for it." State Auditor Rob Sand hosted a town hall in Scott County last week, where he said he fielded several questions on education savings accounts passed by the Legislature in 2023.

SEATTLE — This summer, therapist Michelle Ehle added a new offering to her practice: a weekly group focused on getting through the presidential election. Clients were bringing up politics during ...

CNN commentator and New York Times reporter Maggie Haberman said there’s “no question” former President ... angrier and he seems a little more focused on talking openly about revenge ...

Our platform caters to various client needs, from DIY builders who require flexibility in customization to turn-key buyers looking for ready-to-use solutions. Focused on the U.S. market ...

We also discuss the impact that Pfizer’s failed gene therapy in Duchenne may have on other companies developing next-generation treatments, and noodle over Novo Holdings’ controversial plan to ...

JACKSONVILLE, Fla. — Nymbus announces a strategic partnership with PeoplesBank to launch two products, “Employer-led Bank” and “Union Workers Financial Services” (UWFS). This collaboration targets the ...

In a CNN town hall held in Philadelphia, Vice President Kamala Harris acknowledged the tragic loss of civilian lives in Gaza but avoided directly answering a question about preventing further ...

Ocuphire still focused on FDA approval ... towards the acquired gene therapy programs.” Ocuphire's Ryzumvi, also known as phentolamine ophthalmic solution, was approved by the FDA a year ago ...

It's on to the Denver Broncos in Carolina Panthers head coach Dave Canales' eyes. Canales treated fans and reporters to plenty of coach speak during his Monday press conference when asked whether ...

Confounding data from a Pfizer clinical trial has rattled the field of gene therapy for Duchenne muscular dystrophy, raising more questions about the regulatory standard used to approve a ...